SCHEMBL18568245

SCHEMBL18568245

COC(=O)CNC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](N)CCCCN

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MMP2 P08253 1/20 0.35
▸ DPP8 Q6V1X1 1/20 0.35
▸ DPP9 Q86TI2 1/20 0.35
▸ DPP7 Q9UHL4 1/20 0.35
▸ CD40 P25942 2/20 0.35
▸ TERT O14746 1/20 0.35
▸ SLC15A2 Q16348 1/20 0.35
▸ PSMB1 P20618 1/20 0.34
▸ PSMB8 P28062 1/20 0.34
▸ PSMB9 P28065 1/20 0.34
▸ PSMB5 P28074 1/20 0.34
▸ PSMB10 P40306 1/20 0.34
▸ PSMB2 P49721 1/20 0.34
▸ GNAI3 P08754 1/20 0.34
▸ GNAO1 P09471 1/20 0.34
▸ GNAI1 P63096 1/20 0.34
▸ ERAP2 Q6P179 2/20 0.34
▸ LNPEP Q9UIQ6 1/20 0.34
▸ GHSR Q92847 4/20 0.34
▸ ERAP1 Q9NZ08 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9616877 0.89 MMP2 (0.39) MMP2DPP8DPP9DPP7CD40
SCHEMBL7160638 0.89 MMP2 (0.37) MMP2DPP8DPP9DPP7CD40
SCHEMBL8427968 0.89 MMP2 (0.39) MMP2DPP8DPP9DPP7CD40
SCHEMBL9200315 0.89 MMP2 (0.39) MMP2DPP8DPP9DPP7CD40
SCHEMBL7160634 0.89 MMP2 (0.37) MMP2DPP8DPP9DPP7CD40
SCHEMBL8953758 0.88 GNAI3 (0.41) DPP8DPP9DPP7GNAI3GNAO1
SCHEMBL9747593 0.88 GNAI3 (0.41) DPP8DPP9DPP7GNAI3GNAO1
SCHEMBL9183876 0.87 MMP2 (0.36) MMP2DPP8DPP9DPP7CD40
SCHEMBL29484171 0.86 SLC15A2 (0.41) MMP2CD40TERTSLC15A2PSMB1
SCHEMBL9642989 0.86 MMP2 (0.39) MMP2DPP8DPP9DPP7CD40

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9586989-B1 Non-toxic skin cancer therapy with copper peptides SKIN BIOLOGY, INC. (US) 2017-03-07 — — US disclosed
Send feedback